Literature DB >> 16132341

Insulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(L-lactide): bioavailability and nasal tolerability in rats.

Michael Simon1, Matthias Wittmar, Thomas Kissel, Thomas Linn.   

Abstract

PURPOSE: The bioavailability and local tolerability of insulin containing nanocomplexes from amine-modified poly(vinyl alcohol)-graft-poly(L-lactide) were studied in rats. Histology of the nasal epithelium was studied to document integrity of the mucosa.
METHODS: Nanocomplexes (NC) were prepared by spontaneous self-assembly of insulin and the water-soluble amphiphilic polymer. Changes in blood glucose and insulin blood concentration were monitored in anesthetized rats using a glucose meter and enzyme-linked immunosorbent assay, respectively. Histological sections of the nasal cavity were examined after H&E staining by light microscopy.
RESULTS: NC reduced blood glucose level in fasted healthy rats by 20% after 50-80 min and in streptozotocin induced diabetic rats by 30% within 75-95 min compared to basal levels. In both animal models significant concentrations of human insulin were detected, with relative bioavailabilities F(rel) of 2.8 up to 8.3%. The more hydrophobic, lactic acid grafted polyester were more effective at a threefold higher polymer concentration, increasing the relative bioavailability F(rel) of a 5 IU/kg dose from 2.8 to 5.7%. Histological examination of the nasal mucosa after 4 h showed no signs of toxicity at the site of nasal administration.
CONCLUSIONS: These results demonstrate that the NC significantly enhanced insulin absorption, suggesting that amphiphilic biodegradable comb-polymers offer a promising approach for nasal peptide delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132341     DOI: 10.1007/s11095-005-7676-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Intranasal insulin delivery and therapy.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-02-01       Impact factor: 15.470

2.  Transmucosal macromolecular drug delivery.

Authors:  C Prego; M García; D Torres; M J Alonso
Journal:  J Control Release       Date:  2005-01-03       Impact factor: 9.776

3.  Role of surfactants in the bioavailability of intranasal insulin.

Authors:  A Sanchez; P Ygartua; D Fos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991       Impact factor: 2.441

4.  Study of nasal enzyme activity towards insulin. In vitro.

Authors:  S Gizurarson; E Bechgaard
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-08       Impact factor: 1.645

5.  Transport of nanoparticles across the rat nasal mucosa.

Authors:  J Brooking; S S Davis; L Illum
Journal:  J Drug Target       Date:  2001       Impact factor: 5.121

6.  Altered responses to environmental stress in streptozotocin-diabetic rats.

Authors:  L L Bellush; W N Henley
Journal:  Physiol Behav       Date:  1990-02

Review 7.  Novel methods of insulin delivery: an update.

Authors:  D J Chetty; Y W Chien
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1998       Impact factor: 4.889

8.  Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.

Authors:  L A Dailey; E Kleemann; M Wittmar; T Gessler; T Schmehl; C Roberts; W Seeger; T Kissel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

9.  New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.

Authors:  C Damgé; C Michel; M Aprahamian; P Couvreur
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

10.  Charge selectivity of rat intestinal capillaries. Influence of polycations.

Authors:  D N Granger; P R Kvietys; M A Perry; A E Taylor
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682

View more
  2 in total

1.  Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy.

Authors:  Ratnesh Jain; Swapna Nabar; Prajakta Dandekar; Vandana Patravale
Journal:  Pharm Res       Date:  2010-02-12       Impact factor: 4.200

Review 2.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.